Edesa Biotech Inc reports results for the quarter ended in September - Earnings Summary

Edesa Biotech

28/12/2021 22:54

* Edesa Biotech Inc  EDSA.OQ  reported a quarterly adjusted loss
of 27 cents​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 37 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Edesa Biotech Inc's reported EPS for the quarter was a loss
of 27 cents​.
* The mean earnings estimate of analysts had fallen by
about 6.3% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Edesa Biotech Inc shares had fallen by 17.5% this quarter and
gained 43.3% so far this year.
* The company reported a quarterly loss of $3.69 million.
* Wall Street's median 12-month price target for Edesa Biotech
Inc is $18.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated December 28 at 10:53 p.m.
 ​All figures in US dollars unless otherwise stated